Sfoglia per Autore ZACCARELLO, GIANLUCA
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation
2015-01-01 Morandi, Fabio; Morandi, Barbara; Horenstein, Alberto L.; Chillemi, Antonella; Quarona, Valeria; Zaccarello, Gianluca; Carrega, Paolo; Ferlazzo, Guido; Mingari, Maria Cristina; Moretta, Lorenzo; Pistoia, Vito; Malavasi, Fabio
Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche.
2015-01-01 Quarona, V; Ferri, V; Chillemi, A; Bolzoni, M; Mancini, C; Zaccarello, G; Roato, I; Morandi, F; Marimpietri, D; Faccani, G; Martella, E; Pistoia, V; Giuliani, N; Horenstein, Al; Malavasi, F
CD38 and bone marrow microenvironment.
2014-01-01 Chillemi A;Zaccarello G;Quarona V;Lazzaretti M;Martella E;Giuliani N;Ferracini R;Pistoia V;Horenstein AL;Malavasi F
CD38 e autismo. Genetica e ricadute nella pratica clinica
2013-01-01 Brunetti Enrico; Zaccarello Gianluca; Chillemi Antonella; Fusco Roberta; Quarona Valeria; Cometa Luisa; Gandione M; Balzola F; Omedè Paola; Geuna Massimo; Rigardetto R; Horenstein AL; Malavasi Fabio
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule.
2013-01-01 Chillemi A;Zaccarello G;Quarona V;Ferracin M;Ghimenti C;Massaia M;Horenstein AL;Malavasi F
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes.
2013-01-01 Horenstein AL;Chillemi A;Zaccarello G;Bruzzone S;Quarona V;Zito A;Serra S;Malavasi F
CD38 and CD157: A long journey from activation markers to multifunctional molecules.
2013-01-01 Quarona V;Zaccarello G;Chillemi A;Brunetti E;Singh VK;Ferrero E;Funaro A;Horenstein AL;Malavasi F
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib
2011-01-01 Valabrega G; Capellero S; Cavalloni G; Zaccarello G; Petrelli A; Migliardi G; Milani A; Peraldo-Neia C; Gammaitoni L; Sapino A; Pecchioni C; Moggio A; Giordano S; Aglietta M; Montemurro F.
The hidden life of NAD+-consuming ectoenzymes in the endocrine system.
2010-01-01 Malavasi F; Deaglio S; Zaccarello G; Horenstein A; Chillemi A; Audrito V; Serra S; Gandione M; Zitella A; Tizzani A
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation | 2015 | Morandi, Fabio; Morandi, Barbara; Horenstein, Alberto L.; Chillemi, Antonella; Quarona, Valeria; Zaccarello, Gianluca; Carrega, Paolo; Ferlazzo, Guido; Mingari, Maria Cristina; Moretta, Lorenzo; Pistoia, Vito; Malavasi, Fabio | |
Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche. | 2015 | Quarona, V; Ferri, V; Chillemi, A; Bolzoni, M; Mancini, C; Zaccarello, G; Roato, I; Morandi, F; Marimpietri, D; Faccani, G; Martella, E; Pistoia, V; Giuliani, N; Horenstein, Al; Malavasi, F | |
CD38 and bone marrow microenvironment. | 2014 | Chillemi A;Zaccarello G;Quarona V;Lazzaretti M;Martella E;Giuliani N;Ferracini R;Pistoia V;Horenstein AL;Malavasi F | |
CD38 e autismo. Genetica e ricadute nella pratica clinica | 2013 | Brunetti Enrico; Zaccarello Gianluca; Chillemi Antonella; Fusco Roberta; Quarona Valeria; Cometa Luisa; Gandione M; Balzola F; Omedè Paola; Geuna Massimo; Rigardetto R; Horenstein AL; Malavasi Fabio | |
Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule. | 2013 | Chillemi A;Zaccarello G;Quarona V;Ferracin M;Ghimenti C;Massaia M;Horenstein AL;Malavasi F | |
A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes. | 2013 | Horenstein AL;Chillemi A;Zaccarello G;Bruzzone S;Quarona V;Zito A;Serra S;Malavasi F | |
CD38 and CD157: A long journey from activation markers to multifunctional molecules. | 2013 | Quarona V;Zaccarello G;Chillemi A;Brunetti E;Singh VK;Ferrero E;Funaro A;Horenstein AL;Malavasi F | |
HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib | 2011 | Valabrega G; Capellero S; Cavalloni G; Zaccarello G; Petrelli A; Migliardi G; Milani A; Peraldo-Neia C; Gammaitoni L; Sapino A; Pecchioni C; Moggio A; Giordano S; Aglietta M; Montemurro F. | |
The hidden life of NAD+-consuming ectoenzymes in the endocrine system. | 2010 | Malavasi F; Deaglio S; Zaccarello G; Horenstein A; Chillemi A; Audrito V; Serra S; Gandione M; Zitella A; Tizzani A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile